Erasca, Inc.

ERAS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$17.84-1.71%

2026-08-03

Financials

Valuation Metrics

Erasca, Inc.'s Market Cap is $5.55B. At end of 2025 it was $1.05B. Ranked #1301 of 3,111 in US market (top 42%), #439 of 1,445 on NASDAQ (top 30%), #77 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 29%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$5.55B	US#1,301/3,111 Sec#77/269
Revenue	$0.00	US#2,980/3,111 Sec#205/269
Net Income	$-277M	US—/3,111 Sec—/269
Total Assets	$461M	US#2,784/3,111 Sec#170/269
Net Assets	$394M	US#2,421/3,111 Sec#137/269
Value
P/B	14.10x	US#2,730/3,111 Sec#218/269
FCF Yield	-1.65%	US—/3,111 Sec—/269
Profitability
ROE	-70.39%	US#2,805/3,111 Sec#200/269
ROA	-60.06%	US#3,011/3,111 Sec#238/269
Financial Health
Debt Ratio	17.20%	US#194/3,111 Sec#74/269
Total Debt	$46M	US#2,596/3,111 Sec#153/269
FCF	$-91M	US#2,578/3,111 Sec#145/269
Cash	$47M	US#2,618/3,111 Sec#234/269
Current Ratio	9.52x	US#258/3,111 Sec#85/269
Performance
1Y Return	1183.45%	US#3/3,111 Sec#1/269
1M Return	-3.41%	US#1,358/3,111 Sec#87/269
From 52W High	-26.52%	US#1,908/3,111 Sec#135/269
1Y MDD	-59.46%	US#2,700/3,111 Sec#211/269
Trading
Volume	2,572,305 shares	US#675/3,111 Sec#53/269
Trading Value	$45M	US#1,333/3,111 Sec#84/269
Per Share
EPS	$-0.44	US—/3,111 Sec—/269
BPS	$1.15	US#2,608/3,111 Sec#199/269